Drug Approvals Quarterly Update: April 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

publications High Cost Therapy Profile: January 2025 Tabelecleucel Intravenous (IV) Oncology January 8, 2025 Proposed indications Epstein-Barr virus-positive (EBV+) post-transplant...

publications High-Cost Therapy Profile: June 2025 Zopapogene imadenovec Subcutaneous (SC) | Precigen, Inc. Infectious Disease June 18, 2025 Proposed indications Recurrent respiratory...

Jessica Johnson, clinical consultant at Prime Therapeutics, shares how the Special Investigations Unit (SIU) helps prevent fraud, waste and abuse (FWA) in health care

research 8 research posters presented by Prime at the 2024 AMCP Annual Meeting Prime remains at the forefront of researching real-world drug utilization, managed care pharmacy programs, and costs...

AMCP Annual Meeting 2025 research posters Studies include Prime’s GLP-1 obesity research and a Medicare drug cost predictive model Click on the poster image to view the full-size version. Prime...

Help lower costs with biosimilars We actively promote evidence-based use of biosimilars to help you make the most of your integrated drug strategy. Breadcrumb Home Our solutions Condition...

publications Weight management: A holistic journey May 1, 2024 Obesity is a global epidemic and major public health issue that has grown in prevalence over recent decades in adults, adolescents...

Expert Clinical Network Insights Hemophilia December 17, 2024 Medication insights: marstacimab-hncq (Hympavzi) The U.S. Food and Drug Administration (FDA) approved marstacimab-hncq (Hympavzi) in...

publications Drug Approvals: July 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches July 31, 2024 Specialty New drugs Jun. 20,...

PUBLICATIONS FDA Decisions Expected: February 2025 Drug pipeline for February 2025 January 15, 2025 Your monthly synopsis of new drugs expected to hit the market At Prime Therapeutics (Prime), we...

PUBLICATIONS FDA Decisions Expected: May 2025 Your monthly synopsis of new drugs expected to hit the market April 14, 2025 Drug pipeline for May 2025 At Prime Therapeutics (Prime), we have...

publications High-Cost Therapy Profile: May 2025 Vusolimogene oderparepvec Intratumoral | Replimune Oncology-Gene therapy May 15, 2025 Proposed indications Advanced melanoma FDA approval...

publications Drug Approvals: February 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches February 28, 2025 Specialty New drugs...

Event features discussions about health care industry trends, best practices and innovations

Special Investigations Unit helps promote safety to prevent fraud, waste and abuse schemes

Cover image for Drug Approvals Monthly Update: September 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...

Cover image for Drug Approvals Monthly Update: August 2024 This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals provides a review of newly approved specialty...

Drug Approvals Quarterly Update: January 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process....

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

publications High-Cost Therapy Profile: April 2025 Deramiocel Intravenous (IV) | Nippon Shinyaku Co., Ltd./Capricor Therapeutics, Inc. Cardiovascular/Musculoskeletal April 15, 2025 Proposed...

In this episode, our experts discuss Prime’s four primary tenets of practice for chronic weight management.

publications Drug Approvals: January 2025 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches January 31, 2025 Specialty New drugs Dec....

publications Drug Approvals: December 2024 Monthly update on newly approved specialty and traditional drugs, new indications and first-time generic launches December 30, 2024 Specialty New drugs...

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process.

Drug Approvals Quarterly Update: July 2024 This wrap-up provides a review of newly approved drugs, recent drug launches, new indications and news of note on drugs in the approval process. Prime...

Event features Prime experts

Reimagine your pharmacy benefit partner Designed by health plans for health plans, we provide an innovative pharmacy benefit manager (PBM) partnership experience. Breadcrumb Home Who we are About...

research 10 research posters presented by Prime at AMCP Nexus 2024 Studies include Prime’s GLP-1 obesity research, health equity, and real world case studies October 18, 2024 Evaluating the...

Help your members on high-cost clinical drugs Our deep expertise and holistic view of patient care help you manage the most complex conditions and expensive specialty drugs across both pharmacy...

Formulary design recommendations help create competition to drive savings, provide optionality to meet unique client needs.

Help your members take their health to the next level KeepWell™ offers a personalized and effective path to wellness, supporting members with obesity, diabetes, hypertension and high cholesterol....

Discover next-gen pharmacy solutions We deliver innovative pharmacy benefit management and a differentiated experience that puts customer and member needs first Breadcrumb Home Who we are About us...

'Pharmacy Friends' "Pharmacy Friends" is a podcast dedicated to bringing industry experts to the same table to talk about what is happening in pharmacy today, what is coming in the future and, most...

Oncology Insights Oncology Case Management and Navigation: How do they differ? October 14, 2024 Caring for and treating a patient with cancer is complex. Many patients struggle to coordinate...

In this special episode of the Pharmacy Friends podcast, “Live at Specialty Summit ’24 – Connect. Elevate. Transform.,” we are on the road in New York City at our 21st annual Specialty Summit. More...

Annual meeting will feature industry research posters and educational sessions

2024 AMCP Annual Posters As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Annual Meeting. Click on the poster image to view the full-size version. Save: Making medications more...

Support members with autoimmune diseases We help members navigate their autoimmune diseases with our holistic, customized approach to care. Breadcrumb Home Our solutions Condition management...

Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) High Cost Therapy Profile Gene Therapy/Immunology Marnetegragene autotemcel...

The SIU promotes safety to prevent fraud, waste and abuse schemes

publications High Cost Therapy Profile: December 2024 Remestemcel-L Intravenous (IV) Mesoblast Limited December 11, 2024 Autoimmune/immunology Proposed indications Treatment of...

Support members with rare diseases We help members navigate rare diseases with our holistic, customized approach to care. Breadcrumb Home Our solutions Condition management Rare diseases Learn more...

Cover AMCP Prime Therapeutics /amcp-nexus-2024-research-posters 10 research posters presented by Prime at AMCP Nexus 2024 covers topics like GLP-1 obesity research, health equity initiatives, and...

Cover image for 8 research posters presented by Prime at the 2024 AMCP Annual Meeting 2024 AMCP Annual Meeting Prime Therapeutics /2024-amcp-annual-meeting-research-posters 8 research posters...

If you think about the rise of specialty drugs as a Category 5 hurricane, and the growth of gene therapies as an undersea earthquake, you can see the rising tsunami of drug spend looking to sweep...

Prime Therapeutics offers first-of-its-kind digital utilization management solution that pairs biomarker testing with targeted therapy drug selection

2024 AMCP Nexus Posters As presented at the 2024 Academy of Managed Care Pharmacy (AMCP) Nexus event. Click on the poster image to view the full-size version. Save: Making medications more...

Constant communication across the supply chain limits disruption when a drug is unavailable

Prime works to simplify medication management and support patients with migraine, making migraine treatment less of a pain point

publications Trending Topics & Drug Approvals: May 2025 Your source for the latest drug information highlights June 4, 2025 Trending Topics Hot topics The United States (U.S.) Food and Drug...

Parikh, director of medical pharmacy strategy at Prime/MRx, shares the latest on interchangeable biosimilars

Prime Therapeutics/Magellan Rx Management's signature event featured the hottest topics in specialty drug management and more

oncology insights Oncology Insights: 2024 Rewind January 16, 2025 Last year, Oncology Insights brought you the most talked about topics in 2024. As we enter this new year, let us review these...

Lead author David Eckwright shares more about the study “Real-World Extended Dosing Assessment for Eye(s) new to Faricimab-svoa Therapy.”

See our history Our teams have poured energy, integrity and compassion into transforming pharmacy solutions, turning barriers into breakthroughs. Breadcrumb Home Who we are Our history Tab 1 2021 –...

Prime’s Special Investigations Unit is specially trained to protect patients and providers throughout the health care continuum

New report highlights value-based contract solution and analysis of top 10 drug classes impacting Medicaid pharmacy net trend

Hero headline Forward copy that anchors in the key themes of our campaign: we are an organization you can trust, with solutions built for every plan, and people who will work to do what is right...